Le Lézard
Classified in: Health, Business
Subjects: PDT, BFA, CXP

Athletico Physical Therapy Opens in Mansfield, Texas


Athletico is looking forward to continuing its quality of care throughout the state of Texas

MANSFIELD, Texas, Nov. 14, 2022 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Mansfield, Texas, located across the street from Mansfield High School, next to Mary Orr Intermediate School. This location offers convenient hours, including early morning and late evening appointments, and does not require a referral or prescription to start treatment. To learn more, or to schedule a free assessment, visit www.athletico.com/Mansfield.

"Born and raised in Mansfield, I look forward to reconnecting with the community and building a great clinic with a patient friendly atmosphere," said Cherie Gilliland, PT, DPT and Clinic Manager of Athletico Mansfield. "At Athletico, our team of physical therapists will take the time to fully evaluate your injury and educate you in a way that you will understand the recovery process, as well as how to prevent future injuries from occurring."

In addition to in-clinic treatment at Mansfield, Athletico is expanding access to care by offering virtual appointments from the convenience of your own home. Patients have the option to have their condition assessed and treated virtually by a licensed physical therapist through a secure online video chat. 

Services available at Athletico Mansfield include:

Additionally, Athletico Mansfield:

Athletico ? Mansfield
3020 East Broad St., Suite 112
Mansfield, TX 76063
Phone: 682-422-7580
www.athletico.com/Mansfield
[email protected] 

About Athletico Physical Therapy

Athletico Physical Therapy provides the highest quality orthopedic rehabilitation services to communities, employers and athletes. With its recent acquisition of Pivot Health Solutions, the company has nearly 8,000 employees across more than 900 locations throughout 24 states and the District of Columbia. Athletico is committed to our patients and referring physicians through our patient-centric focus, positive work environment, attention to quality and high standard of care. Athletico measures patient outcomes and satisfaction and is dedicated to continuous improvement. Athletico was named #1 Workplace in Chicago, "Best Physical Therapy Practice in the Nation" by ADVANCE magazine, Top Workplace in the Nation and has been recognized as a leader in employee volunteering and charitable giving. Our services include physical and occupational/hand therapy, workers' compensation, women's health therapy, concussion management and athletic training. For more information, or to schedule a free assessment in clinic or now online with our virtual free assessments, visit http://www.athletico.com and follow us on Twitter at @athletico.

Media Contact:
Dana Andreoli
Athletico Physical Therapy
[email protected] 
630-259-5156

SOURCE Athletico Physical Therapy


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: